Johnson & Johnson news and information

Obesity is still rising, but at a slower pace, which some experts say may be a sign people are finally responding to a smattering of policy initiatives and an outpouring of national concern.
FULL STORY »

The orthopedic unit of Johnson & Johnson said that it was phasing out production of all-metal replacement hips, a move reflecting an industrywide trend to abandon the once widely used implants because of high early failure rates.
FULL STORY »

Physicians and nurse practitioners agree that NPs should practice “to the full extent of their license.” But the two groups strongly disagree on whether doctors and nurse practitioners should receive equal pay for providing the same services and on whether NPs can lead a...
FULL STORY »

Novartis, the Swiss drugmaker already under a strict corporate-integrity agreement because of a past settlement, was targeted by two lawsuits last week by the U.S. attorney's office for New York City alleging widespread payments of illegal kickbacks.
FULL STORY »

Sense4Baby, a San Diego startup medical device company, has named Dr. Jessica Grossman its president and CEO.
FULL STORY »

UnitedHealthcare and about 50 hospitals say they will conduct research comparing some of the costliest medical devices and then use that data to inform their purchasing decisions.
FULL STORY »

A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.
FULL STORY »

The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine.
FULL STORY »

Health products giant Johnson & Johnson on Monday issued yet another product recall, this one for OneTouch VerioIQ blood glucose meters sold in the U.S. and other countries.
FULL STORY »

A jury Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson's DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant that was later recalled. Jurors found that the ASR XL implant was defectively designed and caused metal poisoning and other health...
FULL STORY »